Canadian health sciences company MDS Incsaid is selling its late-stage pharma services unit to INC Research for $50 million. The unit--which covers Phase II to IV development--employs 800 workers and conducts trials in more than 25 countries. Report
Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product
Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.